Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY: TMO )

519.88 +11.41 (+2.24%)
Streaming Delayed Price Updated: 2:50 PM EDT, Mar 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
23 24 Next >
7 Value Stocks That Are Too Cheap to Ignore
With market and economic forces eschewing growth-focused companies, now may be the time to consider cheap value stocks to buy. 
Via InvestorPlace
Check Out What Whales Are Doing With TMO
Someone with a lot of money to spend has taken a bearish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 26, 2022
From Thermo Fisher Scientific Inc.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Thermo Fisher Scientific to Source Half of its U.S. Electricity Needs from Wind Power Purchase with Enel North America
From Thermo Fisher Scientific Inc.
Via Business Wire
Thermo Fisher Invests $160M to Expand Bioproduction Capacity
Via Benzinga
Expert Ratings for Thermo Fisher Scientific
Analysts have provided the following ratings for Thermo Fisher Scientific (NYSE:TMO) within the last quarter: 
Via Benzinga
Thermo Fisher's Oncomine Dx Test Is First FDA Approved NGS-Based Companion Diagnostic To Detect Thyroid Cancers
Via Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Via Benzinga
Can Healthcare Stocks Continue To Outperform?
Large-cap healthcare and biotech stocks have been resilient amidst the market turmoil caused by rising rates and the global geopolitical crisis. 
Via Talk Markets
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
Where Thermo Fisher Scientific Stands With Analysts
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here
Susquehanna cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $195. Susquehanna analyst Shyam Patil maintained the stock with a Positive rating. Baidu shares rose 0.7% to $139.38 in... 
Via Benzinga
Trump Ally Dr. Oz Hyped Unapproved 'Covid Cures' From Companies He Owns Shares Of
Republican Pennsylvania Senate candidate Dr. Mehmet Oz owns shares of two companies he publicly supported, touting their drugs as potential Covid-19 treatments — even though the drugs weren't approved... 
Via Benzinga
Thermo Fisher Scientific to Present at Morgan Stanley 2022 Global Healthcare Conference
From Thermo Fisher Scientific Inc.
Via Business Wire
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,000 Today
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 9.91% on an annualized basis producing an average annual return of 16.88%. Currently, Thermo Fisher Scientific... 
Via Benzinga
Check Out What Whales Are Doing With TMO
Someone with a lot of money to spend has taken a bearish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on publicly... 
Via Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
Expert Ratings for Thermo Fisher Scientific
Over the past 3 months, 5 analysts have published their opinion on Thermo Fisher Scientific (NYSE:TMO) stock. These analysts are typically employed by large Wall Street banks and tasked with... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Thermo Fisher Scientific
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
Upgrades 
Via Benzinga
The 7 Safest Blue-Chip Dividend Stocks to Buy for the Rest of 2022
Investors are wise to consider the safest blue-chip dividend stocks as this year's volatility may only be getting started. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Agilent Puts Together Commanding Beat That Ignores Messy Medtech Dynamics
Agilent managed to stave off challenges due to Covid and exchange rates for a big beat. 
Via Investor's Business Daily
The 3 Best Vanguard Funds to Buy in August
VCR, VHT and VYM are among the best Vanguard funds to buy now. Here is why they will make great investments in the coming months. 
Via InvestorPlace
Check Out What Whales Are Doing With Thermo Fisher Scientific
  Someone with a lot of money to spend has taken a bearish stance on Thermo Fisher Scientific (NYSE:TMO). And retail traders should know. We noticed this today when the big position showed up on... 
Via Benzinga
Earnings Continue to Win
In today’s Market360, we are going to look at three companies’ earnings that were recently upgraded in Portfolio Grader and see whether it’s time to buy. 
Via InvestorPlace
Here's How Much $1000 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 20 years by 11.6% on an annualized basis producing an average annual return of 19.59%. Currently, Thermo Fisher Scientific... 
Via Benzinga
Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution for Real-Time Cryo-EM Data Analysis
From Thermo Fisher Scientific Inc.
Via Business Wire
What 4 Analyst Ratings Have To Say About Thermo Fisher Scientific
Within the last quarter, Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst ratings: 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.